Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-002385

Chief Scientific Officer sold 3,155 shares at $15.17 ($47,861)

  • Chief Scientific Officer acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Townson Sharon Chief Scientific Officer 2026-01-02 Grant or award +35,000 71,000 D
Townson Sharon Chief Scientific Officer 2026-01-05 Sale −3,155 $15.17 $47,861 67,845 D
Derivatives
Townson Sharon Chief Scientific Officer 2026-01-02 Grant or award · Stock Option (Right to Buy) +158,000 158,000 D
Open-market sales · 3,155 sh · avg $15.17 · $47,861
Loading xslF345X05/ownership.xml…